Location History:
- Belleville, NJ (US) (1976 - 1982)
- Glen Ridge, NJ (US) (1982 - 2010)
Company Filing History:
Years Active: 1976-2010
Title: Giacomo Pizzolato: Innovator in Anticancer Compounds
Introduction
Giacomo Pizzolato, based in Belleville, NJ, has made significant contributions to the field of pharmaceuticals through his innovations. With a remarkable portfolio of 24 patents, his work focuses primarily on developing compounds that exhibit anticancer properties.
Latest Patents
One of Pizzolato’s latest patents involves 4,4,5,5, tetrasubstituted imidazolines. This compound, along with its pharmaceutically acceptable salts and esters, demonstrates promising activity as anticancer agents. Another notable patent details 7,8-disubstituted pyrazolobenzodiazepines. This invention includes compounds that facilitate the inhibition of kinases, particularly CDK2, and aims to treat various cancers, including breast, colon, prostate, and lung cancer.
Career Highlights
Giacomo Pizzolato has built an impressive career at Hoffmann-La Roche Inc., a leading global pharmaceutical company. His innovative work not only advances pharmaceutical science but also opens new avenues for cancer treatment.
Collaborations
Throughout his career, Pizzolato has collaborated with notable colleagues such as Milan R. Uskokovic and Pasquale N. Confalone. These collaborations have further enriched his work and have contributed to the success of their joint research efforts.
Conclusion
Giacomo Pizzolato stands as a notable inventor in the realm of pharmaceuticals, particularly in the field of anticancer agents. His numerous patents reflect his dedication to innovation and the pursuit of effective treatments for challenging diseases.